Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Colorectal Neoplasms

Free Subscription 26.10.2026 1 Am J Clin Oncol 1 Am J Surg 8 Ann Surg Oncol 1 BMC Cancer 1 BMC Gastroenterol 1 Br J Cancer 1 Cancer Lett 2 Eur J Surg Oncol 2 Gastroenterology 3 Gastrointest Endosc 2 Int J Cancer 4 Int J Colorectal Dis 2 J Natl Cancer Inst 2 Lancet 2 Oncogene 3 PLoS One 1 World J Surg

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Clin Oncol

1. EAGLEHOUSE YL, Gage MM, Darmon S, Krell RW, et al
   Sex Differences in Postoperative Outcomes for Men and Women With Colon Cancer in the US Military Health System.
   Am J Clin Oncol. 2026 Oct 19. doi: 10.1097/COC.0000000000001390.
   PubMed         Abstract available
   
   

   
   Am J Surg

2. KRAVCHENKO T, Vitous CA, Bradley SE, Marzoughi M, et al
   "A new normal": A qualitative study of emotional and psychosocial concerns in early-onset colorectal cancer survivors.
   Am J Surg. 2026;262:117291.
   PubMed         Abstract available
   
   

   
   Ann Surg Oncol

3. HORINO T, Komori K, Ishikawa Y, Kataoka K, et al
   ASO Visual Abstract: Prognostic role of Pretreatment Nutritional and Inflammatory Status in Unresectable Metastatic Colorectal Cancer: Supplementary Analysis of JCOG1007.
   Ann Surg Oncol. 2026 Oct 21. doi: 10.1245/s10434-026-20738.
   PubMed        
   
   
4. HORINO T, Komori K, Kataoka K, Kanemitsu Y, et al
   ASO Author Reflections: Host Status and Treatment Vulnerability in Metastatic Colorectal Cancer.
   Ann Surg Oncol. 2026 Oct 19. doi: 10.1245/s10434-026-20744.
   PubMed        
   
   
5. DENYS A, Verstraete A, Geboes K, van Ramshorst GH, et al
   ASO Author Reflections: Para-aortic Lymph Node Metastasis in Colorectal Cancer.
   Ann Surg Oncol. 2026 Oct 19. doi: 10.1245/s10434-026-20803.
   PubMed        
   
   
6. BRYCE-ALBERTI M, Stoffel V, Blanchard I, Chalasani M, et al
   Urban-Rural Disparities in Treatment and Outcomes for Colorectal Liver Metastases in the United States: A SEER-Medicare Analysis.
   Ann Surg Oncol. 2026;33:10029-10037.
   PubMed         Abstract available
   
   
7. VANDE KERCKHOVE FEC, Creemers DMJ, Banken E, Piqeur F, et al
   Evolution of Prognosis and Management in Curative Treatment of Locally Recurrent Rectal Cancer: A Comprehensive Analysis from 2000 to 2023.
   Ann Surg Oncol. 2026;33:10616-10626.
   PubMed         Abstract available
   
   
8. KOBAYASHI K, Kishi Y, Yonamine N, Tsunenari T, et al
   Hepatectomy After Progressive Disease Following Chemotherapy for Colorectal Liver Metastases: A Japanese Nationwide Cohort Study.
   Ann Surg Oncol. 2026;33:10001-10012.
   PubMed         Abstract available
   
   
9. SAWA Y, Ono Y, Shimane G, Hashimoto T, et al
   Successful Redo Right Hepatic Vein Reconstruction for Recurrent Colorectal Liver Metastases After Triple Hepatic Vein Resection: Implications of Late-Onset Venous Stenosis.
   Ann Surg Oncol. 2026;33:10038-10039.
   PubMed         Abstract available
   
   
10. VU JK, Younan E, Karunaratne S, Sutherland S, et al
    Locally Recurrent Rectal Cancer in the Molecular Era: A Scoping Review of Biomarkers of Oncologic Outcome following Salvage Surgery.
    Ann Surg Oncol. 2026;33:10629-10640.
    PubMed         Abstract available
    
    

    
    BMC Cancer

11. LIU J, Song S, Yao W, Ren Y, et al
    FOLFOX-HAIC plus regorafenib for the treatment of unresectable colorectal liver metastases refractory to first and second-line systemic chemotherapy.
    BMC Cancer. 2026;26:1249.
    PubMed         Abstract available
    
    

    
    BMC Gastroenterol

12. GHANTOUS MI, Zayour N, Al Sabagh N, Mchawrab N, et al
    Patient-, endoscopist-, and procedure-related factors associated with adenoma detection in first screening colonoscopies at a Lebanese tertiary hospital: a retrospective cohort study.
    BMC Gastroenterol. 2026;26:663.
    PubMed         Abstract available
    
    

    
    Br J Cancer

13. LEE SJ, Lee I, Lee J, Park C, et al
    Retraction Note: Statins, 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors, potentiate the anti-angiogenic effects of bevacizumab by suppressing angiopoietin2, BiP, and Hsp90alpha in human colorectal cancer.
    Br J Cancer. 2026 Oct 22. doi: 10.1038/s41416-026-03656.
    PubMed        
    
    

    
    Cancer Lett

14. ZHANG M, Song J, Yu S, Liu H, et al
    2-Hydroxyisobutyrylation of SRSF9 regulates CD44 alternative splicing to promote colorectal cancer liver metastasis.
    Cancer Lett. 2026;661:218900.
    PubMed         Abstract available
    
    

    
    Eur J Surg Oncol

15. KERKHOFF TM, Hamers PA, Koopman M, Kok NF, et al
    Real-world survival scenarios for patients with colorectal cancer and synchronous peritoneal metastases.
    Eur J Surg Oncol. 2026;53:112307.
    PubMed         Abstract available
    
    
16. OSE I, Rosen AW, Ngo-Stuyt L, Gogenur I, et al
    Operability and survival in resectable colorectal cancer: A retrospective propensity score-matched study impact of operability in colorectal cancer.
    Eur J Surg Oncol. 2026;53:112306.
    PubMed         Abstract available
    
    

    
    Gastroenterology

17. SEO J, Lee HS, Ladabaum U
    What Men Live By: Family Ties as a Bridge to Persistent Non-Participants in Colorectal Cancer Screening.
    Gastroenterology. 2026 Oct 22:S0016-5085(26)07727.
    PubMed        
    
    
18. DOMINITZ JA, Gawron AJ, McKee GB, Hoggatt KJ, et al
    Impact of Availability of Computer-Aided Detection Devices on Adenoma Detection During Colonoscopy: A Cluster Randomized Study.
    Gastroenterology. 2026;171:870-884.
    PubMed         Abstract available
    
    

    
    Gastrointest Endosc

19. GE PS, Raju GS, Terrazas Morales VG, Liaw GK, et al
    Performance of magnetic resonance imaging in the staging of rectal polyps undergoing endoscopic resection: a U.S. academic cancer center experience.
    Gastrointest Endosc. 2026;104:877-881.
    PubMed         Abstract available
    
    
20. MARTINS OC, Fernandes MV, Milioli NJ, Baraldo S, et al
    Complementary use of white-light endoscopy and narrow-band imaging for postendoscopic mucosal resection scar assessment: a systematic review and diagnostic meta-analysis.
    Gastrointest Endosc. 2026;104:743-751.
    PubMed         Abstract available
    
    
21. VAN BOKHORST QNE, Nass KJ, Reijnders JGP, van der Schaar PJ, et al
    Automated linking of data from the Dutch national endoscopy and pathology databases for continuous monitoring of polyp detection rates: feasibility and first results.
    Gastrointest Endosc. 2026;104:857-868.
    PubMed         Abstract available
    
    

    
    Int J Cancer

22. CHEN Y, Tang D
    From Intestinal Origins to Mammary Targets: Exploring the Potential Role of the Brain-Gut-Microbiota Axis in Pre-Metastatic Conditioning of Breast Tissue in Colorectal Cancer.
    Int J Cancer. 2026 Oct 20. doi: 10.1002/ijc.70681.
    PubMed         Abstract available
    
    
23. CARVAJAL LJ, Shing JZ, Vanegas JC, Ocampo R, et al
    Trends in Incidence Rates of Anogenital Cancers in Costa Rica, 1996-2022.
    Int J Cancer. 2026;159:2940-2950.
    PubMed         Abstract available
    
    

    
    Int J Colorectal Dis

24. OKUGAWA Y, Kitajima T, Shimura T, Imaoka H, et al
    Effectiveness of hochuekkito for colorectal cancer management: protocol for the multicenter randomized controlled AMATERAS study.
    Int J Colorectal Dis. 2026;41:168.
    PubMed         Abstract available
    
    
25. CHEN JJ, Li ZL, Yang Y, Wang ZJ, et al
    Self-expandable metal stents as a bridge to surgery for obstructive colorectal cancer: a propensity score-matched retrospective cohort study.
    Int J Colorectal Dis. 2026;41:167.
    PubMed         Abstract available
    
    
26. STADELHOFER MV, Dalby HR, Thyo A, Emmertsen KJ, et al
    Prehabilitation for colon cancer surgery: a systematic review of quality-of-life outcomes and a feasibility study.
    Int J Colorectal Dis. 2026;41:165.
    PubMed         Abstract available
    
    
27. ZHOU W, Cheng Q, Lin X, Hong X, et al
    Clinicopathological characteristics and outcomes of rectal neuroendocrine tumors according to resection modality.
    Int J Colorectal Dis. 2026;41:164.
    PubMed         Abstract available
    
    

    
    J Natl Cancer Inst

28. VAN DEN PUTTELAAR R, Shi KS, Zhao J, Doria-Rose VP, et al
    Effects of private health insurance coverage gains on colorectal cancer outcomes: a modeling study.
    J Natl Cancer Inst. 2026 Oct 20:djag395. doi: 10.1093.
    PubMed         Abstract available
    
    
29. BRIOLLAIS L, Choi YH, Semotiuk K, Ward T, et al
    Colonoscopy screening outcomes in Lynch syndrome and differential colorectal cancer paths among MLH1/MSH2 carriers.
    J Natl Cancer Inst. 2026 Oct 19:djag392. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Lancet

30. GILL S, Loree J
    Redefining curative treatment for early-stage mismatch repair-deficient colon cancer.
    Lancet. 2026 Oct 21:S0140-6736(26)01612-0. doi: 10.1016/S0140-6736(26)01612.
    PubMed        
    
    
31. CHALABI M, van den Dungen LDW, de Gooyer PGM, Balduzzi S, et al
    Disease-free survival and overall survival after neoadjuvant immunotherapy in mismatch repair-deficient colon cancer in the Netherlands: results of the single-arm, multicentre, phase 2, NICHE-2 trial.
    Lancet. 2026 Oct 21:S0140-6736(26)01602-8. doi: 10.1016/S0140-6736(26)01602.
    PubMed         Abstract available
    
    

    
    Oncogene

32. XIAO Q, Gan Y, Li Y, Fan L, et al
    Correction: MEF2A transcriptionally upregulates the expression of ZEB2 and CTNNB1 in colorectal cancer to promote tumor progression.
    Oncogene. 2026 Oct 21. doi: 10.1038/s41388-026-04006.
    PubMed        
    
    
33. ARAI H, Elliott A, Yang Y, Farrell A, et al
    Activation of the endocytosis pathway stratifies subtypes and therapeutic sensitivity in colorectal cancer.
    Oncogene. 2026 Oct 19. doi: 10.1038/s41388-026-04019.
    PubMed         Abstract available
    
    

    
    PLoS One

34. LIU J, Gu L, You A, Yuan H, et al
    No phenotypes in Ttc22 knockout mice.
    PLoS One. 2026;21:e0361340.
    PubMed         Abstract available
    
    
35. CARILLON S, Faure R, Del Rio M, Lemanski C, et al
    Analysing the implementation and transferability of an enhanced care pathway integrating systematic supportive cancer care and patient-partner support for people living with anal cancer: Protocol for a mixed-methods study in two French cancer centres.
    PLoS One. 2026;21:e0359705.
    PubMed         Abstract available
    
    
36. WANI F, Marrufo IM, Bhavsar V, Whitmer R, et al
    The association of cardiovascular comorbidities with malignant and benign colorectal neoplasms.
    PLoS One. 2026;21:e0356302.
    PubMed         Abstract available
    
    

    
    World J Surg

37. KIM CH, Kim D, Park JH, Pyo DH, et al
    Asymptomatic Portomesenteric Venous Thrombosis After Colorectal Cancer Surgery: Incidence, Natural History, and Implications for Management.
    World J Surg. 2026 Oct 18. doi: 10.1002/wjs.70633.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Colorectal Neoplasms is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum